Adjuvant therapy for patients with high-risk malignant melanoma

This publication has 34 references indexed in Scilit:

• Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomography
  Cancer, 1999
• Positron emission tomography in the detection and management of metastatic melanoma
  Melanoma Research, 1996
• Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up
  Melanoma Research, 1995
• Results of adjuvant interferon study In WHO melanoma programme
  The Lancet, 1994
• Tamoxifen modulation of cisplatin cytotoxicity in human malignancies
  International Journal of Cancer, 1993
• Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma a biologically important observation
  Cancer, 1993
• Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials
  International Journal of Cancer, 1992
• Treatment of Stage IV Malignant Melanoma with Dacarbazine, Carmustine, Cisplatin, and Tamoxifen Regimens: A University of South Florida and H. Lee Moffitt Melanoma Center Study
  Annals of Plastic Surgery, 1992
• Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
  JNCI Journal of the National Cancer Institute, 1989
• A Randomized Trial of Levamisole versus Placebo as Adjuvant Therapy in Malignant Melanoma
  New England Journal of Medicine, 1980